Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
1.540
-0.130 (-7.78%)
Streaming Delayed Price
Updated: 3:21 PM EDT, Aug 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Enveric Biosciences Participating in BIO-Europe Spring®
March 17, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark
March 06, 2025
From
Enveric Biosciences
Via
Business Wire
Keep an eye on the top gainers and losers in Friday's session.
↗
February 28, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via
Chartmill
These stocks have an unusual volume in today's session
↗
February 28, 2025
Volume analysis on 2025-02-28: stocks with an unusual volume in today's session.
Via
Chartmill
Enveric Biosciences CEO Issues Letter to Shareholders
February 27, 2025
From
Enveric Biosciences
Via
Business Wire
These stocks are moving in today's after hours session
↗
February 26, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
What's going on in today's session
↗
February 26, 2025
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
↗
February 26, 2025
Let's dive into the action on the US markets on Wednesday. Here are the most active stocks that are driving the market today.
Via
Chartmill
Dow Dips Over 100 Points; TJX Earnings Top Views
↗
February 26, 2025
Via
Benzinga
Topics
Stocks
Here are the top movers in Wednesday's session.
↗
February 26, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Nasdaq Surges 150 Points; Lowe's Posts Upbeat Earnings
↗
February 26, 2025
Via
Benzinga
Small-Caps Under $2 on the Move: ENVB, ONVO, TRNR, PRSO, PNPN.V Gaining Momentum
February 26, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Derivatives
Intellectual Property
Traders are paying attention to the gapping stocks in Wednesday's session.
↗
February 26, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday.
Via
Chartmill
These stocks are moving in today's pre-market session
↗
February 26, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert
↗
February 26, 2025
U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.
Via
Benzinga
Topics
Stocks
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
↗
February 26, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Tuesday?
↗
February 25, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
EXCLUSIVE: Non-Hallucinogenic Psychedelic Compounds Show Promise For Treating Addiction And ADHD
↗
February 25, 2025
Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
Via
Benzinga
Topics
Derivatives
Intellectual Property
Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent
February 25, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Inks Two Licensing Agreements With Restoration Biologics To Treat Joint Disease
↗
February 04, 2025
Enveric's Akos Biosciences licensed its cannabinoid-COX-2 conjugate technology to Restoration Biologics for joint disease treatments, including osteoarthritis.
Via
Benzinga
Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease
February 04, 2025
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Announces Closing of $5 Million Public Offering
February 03, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
What's going on in today's session
↗
January 31, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Dow Edges Lower; Exxon Mobil Earnings Top Views
↗
January 31, 2025
Via
Benzinga
Topics
Stocks
Which stocks are gapping on Friday?
↗
January 31, 2025
The market is buzzing with gapping stocks on Friday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via
Chartmill
Nasdaq Jumps Over 150 Points; Apple Posts Upbeat Earnings
↗
January 31, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
January 31, 2025
Before the opening bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
↗
January 31, 2025
Via
Benzinga
Enveric Biosciences Announces Pricing of $5 Million Public Offering
January 30, 2025
From
Enveric Biosciences, Inc.
Via
Business Wire
What's going on in today's after hours session
↗
January 30, 2025
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
